Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2030775
Max Phase: Preclinical
Molecular Formula: C24H33FN4O5
Molecular Weight: 476.55
Molecule Type: Small molecule
Associated Items:
ID: ALA2030775
Max Phase: Preclinical
Molecular Formula: C24H33FN4O5
Molecular Weight: 476.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)OC(=O)N1OC2CCC1C21CCN(c2ccc(N3C[C@H](CN)OC3=O)cc2F)CC1
Standard InChI: InChI=1S/C24H33FN4O5/c1-23(2,3)33-22(31)29-19-6-7-20(34-29)24(19)8-10-27(11-9-24)18-5-4-15(12-17(18)25)28-14-16(13-26)32-21(28)30/h4-5,12,16,19-20H,6-11,13-14,26H2,1-3H3/t16-,19?,20?/m0/s1
Standard InChI Key: PPLIFGHJAYECJA-DZIBYMRMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 476.55 | Molecular Weight (Monoisotopic): 476.2435 | AlogP: 3.41 | #Rotatable Bonds: 3 |
Polar Surface Area: 97.57 | Molecular Species: BASE | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.22 | CX LogP: 2.72 | CX LogD: 0.91 |
Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.71 | Np Likeness Score: -0.54 |
1. Ji C, Lin W, Moraski GC, Thanassi JA, Pucci MJ, Franzblau SG, Möllmann U, Miller MJ.. (2012) Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction., 20 (11): [PMID:22560837] [10.1016/j.bmc.2012.04.026] |
Source(1):